Concepedia

Zeqiang Zhou

ZZ

Statistics

Publications

5

Citations

177

H-Index

5

Active since

2019

Affiliations

Shenzhen Second People's Hospital(Current)

ShenZhen People’s Hospital

Zeqiang Zhou is an author at Shenzhen Second People's Hospital specializing in oncology, medicine, and molecular oncology.

Publications per year

2019–2024

5

Publications

5

MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma

Chang’e Jin, Xiao Liang, Zeqiang Zhou et al. · Human Cell · 2019 · 79 citations

, , +12

Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial

Huaqiang Zhou, Yaxiong Zhang, Gang Chen et al. · Signal Transduction and Targeted Therapy · 2024 · 34 citations · Full text

, , +11

Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study

Fen Wang, Xia Yuan, Jun Jia et al. · Scientific Reports · 2020 · 31 citations · Full text

, , +8

MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer

Haixia Xu, Yan He, Lin Lin et al. · Biochemical and Biophysical Research Communications · 2021 · 17 citations

, , +11

Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency

Xionghao Pang, Juanjuan Qian, Hua Jin et al. · Journal for ImmunoTherapy of Cancer · 2020 · 16 citations · Full text

, , +17

1–5 of 5